Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
35.94
+1.19 (3.42%)
Oct 9, 2025, 11:19 AM EDT - Market open
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $1.39 billion as of October 9, 2025. Its market cap has increased by 80.94% in one year.
Market Cap
1.39B
Enterprise Value
1.04B
1-Year Change
80.94%
Ranking
Category
Stock Price
$35.94
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $1.39B, an increase of 752.80%. That is a compound annual growth rate of 181.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 1.34B | 108.30% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |